Uroplasty Reports Continued Progress During Second Quarter of F... (ment regulation including when and if we...)

Uroplasty Reports Continued Progress During Second Quarter of Fiscal 2009

Date:10/29/2008

ment regulation, including when and if we receive

approval for marketing products in the United States;

-- the results of clinical trials; and

-- our continued losses and the possible need to raise additional capital

in the future.

We cannot assure you that our clinical trial will produce favorable results, that third-party payors will provide or continue to provide coverage and reimbursement, or reimburse the providers an amount sufficient to cover their costs and expenses, nor can we assure you that we will timely obtain, or even succeed at all at obtaining, a specific "listed" CPT reimbursement code from the AMA for Urgent PC treatments. We further cannot assure that reimbursement or other issues will not further impact our fiscal 2009 results.

For Further Information: Uroplasty, Inc.

David Kaysen, President and CEO, or

Medi Jiwani, Vice President, CFO, and

Treasurer,

952.426.6140

EVC Group

Doug Sherk/Dahlia Bailey

(Investors)

415.896.6820

Chris Gale/Steve DiMattia (Media)

646.201.5431

UROPLASTY, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Operations

(Unaudited)

Three Months Ended Six Months Ended

September 30, September 30,

2008 2007 2008 2007

Net sales $3,920,516 $3,039,543 $8,446,138 $5,988,217

Cost of goods sold 549,199 669,041 1,257,166 1,263,253

Gross profit 3,371,317 2,370,502 7,188,972 4,724,964

Operating expenses

General and

administrative 918,394 1,147,432 1,957,108 1,955,806

Research and

development 327,978 426,997 733,498 933,122

Selling and'/>"/>

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12
Related medicine news :

1. Uroplasty to Present at the Noble Financial Fourth Annual Equity Conference
2. Uroplasty to Host First Quarter Conference Call on July 31
3. Uroplasty Joins the Russell Microcap Index
4. Uroplasty Reports Record Growth for the Fourth Quarter and Fiscal Year 2008
5. Uroplasty to Host Fourth Quarter and Year End Conference Call on June 3
6. Uroplasty to Highlight Urgent PC System at American Urological Association 2008 Annual Meeting
7. Uroplasty Plans to Double Sales Force During Fiscal 2009
8. Uroplasty, Inc. Reports Presentations of Urgent(R) PC Studies at the 2008 Society of Urologic Nurses and Associates Annual Symposium
9. Uroplasty to Present at ROTH Capital Partners 20th Annual OC Growth Stock Conference
10. Uroplasty Expands Marketing Program for Urology Practices
11. Uroplasty, Inc. Announces Pricing of a Public Offering of Its Common Stock

Post Your Comments:

Uroplasty Reports Continued Progress During Second Quarter of F...(ment regulation including when and if we...),Health